Eli Lilly flies to New York the week of a major GLP-1 patent contestation hearing

Eli Lilly flew from Hanscom Field outside Boston to Teterboro Airport late Wednesday night, arriving just after midnight on May 28. The short 53-minute hop on Gulfstream N308EL sets up a day in New York City on a business day when the pharmaceutical giant has a heavy legal calendar.

The same week, the company faces a high-stakes patent hearing in Manhattan federal court. Per legal filings covered by Reuters on Tuesday, a judge is considering arguments from compounding pharmacies challenging the formulation patent on tirzepatide, the active ingredient in Mounjaro and Zepbound. The outcome could affect Eli Lilly’s market dominance in the GLP-1 space. A quick arrival at Teterboro the night before a morning court session is the classic play.

The pattern fits the company’s established travel style. Eli Lilly has made multiple Boston-area trips in recent weeks—including a KBED round trip on May 21 and a San Francisco swing on May 24. Hanscom serves the Kendall Square biotech corridor and top FDA regional offices, making it a recurring northeast hub for Eli Lilly executives.